Hemispherx Biopharma, Inc. Equity Distribution AgreementEquity Distribution Agreement • July 23rd, 2012 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • New York
Hemispherx Biopharma, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, shares of Common Stock, $0.001 par value per share, of the Company (the “Common Stock”) having an aggregate offering price of up to $75,000,000 (the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
